Fibromyalgia is a condition characterized by extreme pain and muscle stiffness. It strikes five million to ten million Americans. Fibromyalgia is often treated with anti-depressants, but newer, more targeted therapies may soon be available.
For more than 20 years, Elizabeth Tross-Deamer suffered the pain of Fibromyalgia. She started taking a new medication, pregabalin, and her pain subsided.
"The memory is better. My relationships are better. People like me a lot more," says Elizabeth.
For the first time in years, this wine author can sleep at night, giving her back energy and stamina during the day. Bernadine Smith took a different drug, milnacipran, and had similar results.
"I didn't have as much depression. I wasn't as fatigued," says Bernadine.
Dr. Philip Mease is testing both drugs in separate studies.
"At least a third of the patients in both trials have experienced, roughly, a 50 percent reduction in pain," Dr. Mease says.
Or the drugs come from different families; pregabalin is a pain reliever, milnacipran an anti-depressant.
"What both of these medications are doing are restoring to a more natural balance the neuro-chemicals in the brain that are off kilter in this condition."
Both drugs are still in trials, but for these two women, the verdict is already in.
Viewers with disabilities can get assistance accessing this station's FCC Public Inspection File by contacting the station with the information listed below. Questions or concerns relating to the accessibility of the FCC's online public file system should be directed to the FCC at 888-225-5322, 888-835-5322 (TTY), or email@example.com.